Yu Zhai

Dr. Yu Zhai


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
YLYueyang Li
Yueyang Li
YZYu Zhai
Yu Zhai
TWTianling Wang
Tianling Wang
SWSiya Wang
Siya Wang
YTYu Tian
Yu Tian
CLChangqing Li
Changqing Li
Rationale: Nucleus pulposus (NP) fibrosis is a contributing factor to intervertebral disc degeneration (IVDD), which lacks an effective treatment. This study focuses on elucidating the role and mechanisms of the TGF-β signaling repressor SKI in NP fibrosis and exploring its therapeutic potential.

19 March 2025 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
ZBZhiqun Bian
Zhiqun Bian
YZYu Zhai
Yu Zhai
YZYuyao Zhang
Yuyao Zhang
TWTianling Wang
Tianling Wang
HLHao Li
Hao Li
CLChangqing Li
Changqing Li
Intervertebral disc degeneration (IVDD) is the leading cause of low back pain and associated disability worldwide. The cartilage endplate (CEP) is a critical structure in maintaining the homeostasis of the intervertebral disc, by exosomes (Exos)-mediated intracellular communication between cartilage endplate stem cells (CESCs) and nucleus pulposus cells (NPCs). However, whether the senescence of CESCs influences the functionality of CESCs-derived Exos (CESCs-Exos) and participates in the progress of IVDD remains unclear. In this study, we explored the role and mechanism of the Exos-based intracellular communication between senescent CESCs and NPCs in IVDD. CESCs isolated from aged individuals (S-CESCs) exhibited high levels of senescence compared with CESCs isolated from young individuals (Y-CESCs). Exos from Y-CESCs (Y-Exos) and from S-CESCs (S-Exos) were extracted and identified. Surprisingly, we found that S-Exos lost the therapeutic effects as the Y-Exos exhibited in mitigating IVDD, and even aggravated IVDD by inducing oxidative stress injury in NPCs. MicroRNA-sequencing revealed significant upregulation of miR-29b-3p expression in S-Exos. Through microRNA target prediction, dual luciferase assays, RNA-sequencing, lentivirus-mediated overexpression and suppression, we demonstrated that miR-29b-3p regulates the expression of FOXO3 and downstream antioxidant enzymes to induce oxidative stress injury in NPCs. In vivo experiments further verified that countering miR-29b-3p by antagomir reversed the detrimental effects of S-Exos in exacerbating IVDD. This work elucidates the role and mechanism of senescent CESCs in disrupting redox homeostasis in the nucleus pulposus and exacerbating IVDD by Exos-mediated intracellular communication and offers an experimental foundation for the selection of proper CESCs-Exos to obtain better therapeutic effects in IVDD.

28 February 2026 in Nature Communications
Verified
Journal Article
Open access
YZYuyao Zhang
Yuyao Zhang
YZYu Zhai
Yu Zhai
CLChao Liu
Chao Liu
MCMinghang Chen
Minghang Chen
YZYang Zhang
Yang Zhang
CLChangqing Li
Changqing Li
Lactate accumulation is a hallmark and contributing factor of intervertebral disc degeneration (IVDD), while the role of protein lactylation caused by lactate accumulation in IVDD remains unclear. Via metabolomics, single-cell RNA-sequencing analysis, and lactylation proteomics, we reveal the lactylome landscape in IVDD and identified superoxide dismutase 1 (SOD1) lactylation at lysine 123 (SOD1K123la) as crucial for IVDD aggravation. Using in vitro site-directed mutagenesis, in vivo generation of SOD1K123R mutant male rats, and in silico molecular dynamics simulations, we find that SOD1K123la alters SOD1 conformation and impairs its enzymatic activity, and induces oxidative damage, and activates p53 pathway in nucleus pulposus cells (NPCs). Notably, we identify a small molecule ZL-01 that inhibits SOD1K123la. NPC-targeted delivery of ZL-01 via collagen type II-targeted peptide-modified extracellular vesicles alleviated IVDD in male rats. Together, these findings clarify the mechanism by which SOD1K123la promotes IVDD aggravation and provide a promising therapeutic strategy for IVDD.

1 December 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
FZFeng Zheng
Feng Zheng
LCLinhai Cao
Linhai Cao
JFJiawei Fu
Jiawei Fu
MLMenglin Luo
Menglin Luo
WYWenbo Yue
Wenbo Yue
CLChenhao Liu
Chenhao Liu
Purpose: Intervertebral disc degeneration (IVDD), a common degenerative disorder, is characterized by chronic inflammation and progressive cell death. PANoptosis, an integrated form of programmed cell death that merges pyroptosis, apoptosis, and necroptosis, has recently emerged as a key contributor to degenerative diseases. Although Toll-like receptor 4 (TLR4) and NLRP12 are known to regulate inflammatory signaling and cell death, their roles in mediating annulus fibrosus cells (AFCs). This study investigated how the TLR4–NLRP12 axis regulates AFC PANoptosis and contributes to IVDD progression. Methods: Single-cell RNA sequencing (scRNA-seq) profiled cell heterogeneity and PANoptosis-related signaling in healthy/degenerative annulus fibrosus (AF) tissues. An in vitro IVDD model was established by treating AFCs with TNF-α to mimic inflammation. NLRP12 knockdown was performed via lentiviral transduction. PANoptosis was assessed by Western blot (cleaved-Caspase-1, cleaved-Caspase-3, p-MLKL, c-GSDMD), TUNEL staining, and flow cytometry. In vivo, a rat IVDD model was induced by acupuncture puncture, followed by TLR4 knockdown via lentiviral injection. X-ray imaging was used to assess intervertebral space height, histology to evaluate disc morphology, and TUNEL assay to detect annulus fibrosus cell death. Results: scRNA-seq revealed an increased abundance of Fibro-AFCs and Adh-AFCs in IVDD, alongside enrichment of cell death-related pathways. PANoptosis-related gene expression and cell death scores were elevated in degenerative samples. In vitro, TLR4 activation induced PANoptosis in AFCs, which was attenuated by either TLR4 inhibition or NLRP12 knockdown. Formation of the PANoptosome complex-characterized by colocalization of Caspase-8, ASC, and RIPK3-was observed in degenerative AFCs. In vivo, TLR4 silencing ameliorated IVDD pathology, as evidenced by improved disc height, and reduced cell death. To our knowledge, this is the first study to identify the occurrence of PANoptosis in AFCs. Conclusion: TLR4 promotes PANoptosis in AFCs through NLRP12 activation, driving IVDD pathogenesis. The TLR4-NLRP12-PANoptosis presents a potential therapeutic target for IVDD.

2 April 2026 in Experimental Cell Research
Verified
Journal Article
Open access
CLChenhao Liu
Chenhao Liu
HLHao Li
Hao Li
JFJiawei Fu
Jiawei Fu
CLChao Liu
Chao Liu
FZFeng Zheng
Feng Zheng
YZYu Zhai
Yu Zhai
Ligamentum flavum hypertrophy (LFH), a major pathological feature of lumbar spinal stenosis, is characterized by fibrosis and extracellular matrix (ECM) remodeling. However, the molecular mechanisms remain unclear. This study investigates the role of Sirtuin 1 (Sirt1), a NAD+-dependent deacetylase, in regulating fibroblast-to-myofibroblast transition (FMT) in LFH. Human LF samples and a rat LFH model were examined using histological, immunohistochemical, and molecular analyses. Single-cell RNA sequencing (scRNA-seq) was performed to explore LF cellular heterogeneity and identify fibrosis-related regulators. In vitro, Sirt1 activity was modulated pharmacologically and genetically to assess its role in fibroblast activation. Transcriptomic and bioinformatic analyses were used to identify downstream pathways, and lentiviral overexpression of Sirt1 in vivo was applied to evaluate therapeutic effects. scRNA-seq revealed fibroblasts as the dominant cell type in LFH and showed Sirt1 downregulation during fibrosis progression. Sirt1 inhibition enhanced FMT in ligamentum flavum cells, increasing α-SMA, Col-I, and Col-III expression via activation of the Smad2/3 signaling pathway. Conversely, Sirt1 overexpression mitigated LF fibrosis and improved sensory function in rats. Loss of Sirt1 promotes fibroblast-to-myofibroblast transition through Smad2/3 activation, while Sirt1 restoration alleviates LFH, suggesting Sirt1 as a promising therapeutic target for LF fibrosis.

Verified
Journal Article
Open access
PDF file
RWRuoyu Wang
Ruoyu Wang
JLJie Li
Jie Li
YZYu Zhai
Yu Zhai
ZWZhaoyi Wu
Zhaoyi Wu
PXPengyu Xia
Pengyu Xia
CLChangqing Li
Changqing Li
Atrophic fracture nonunion is a clinically challenging form of failed bone repair, particularly under inflammatory conditions, but the cell-intrinsic programs that impair the function of skeletal stem/progenitor cells (SSPCs) remain incompletely defined. Here, we integrated public and in-house single-cell RNA sequencing datasets from mouse periosteum, normal fracture healing, and inflammation-associated fracture nonunion models to characterize stromal cell fate changes. Trajectory inference, transcription factor network analysis, and intercellular communication modeling were combined with in vitro and in vivo validation experiments. SSPCs in the nonunion microenvironment were arrested in an undifferentiated state and acquired a pro-inflammatory and pro-ferroptotic phenotype, with enrichment of ferroptosis-related genes including Acsl4. Computational analyses nominated IL-1β as a candidate upstream inflammatory signal, with neutrophils representing a potential source, and linked this signal to NF-κB activation and increased Epas1 activity in SSPCs. In primary SSPCs, IL-1β induced lipid peroxidation, intracellular ferrous iron accumulation, ferroptosis-related protein expression, and impaired osteochondrogenic differentiation. Ferroptosis inhibitor treatment further attenuated IL-1β-induced ferroptosis-related protein changes, supporting pathway specificity. Pharmacological inhibition of EPAS1 with PT2385 attenuated IL-1β-induced ferroptotic stress and restored SSPC differentiation in vitro, while also improving IL-1β-impaired fracture repair in vivo. Mendelian randomization analysis provided additional genetic evidence supporting potential links among IL-1β, EPAS1, and human nonunion risk. Together, these findings suggest that an IL-1β/EPAS1-associated ferroptotic program contributes to SSPC dysfunction during inflammation-associated fracture nonunion and may represent a potential targetable mechanism for improving impaired bone repair.